**Core Concept:**
Direct Coombs test is a laboratory test that detects the presence of antibodies (autoantibodies or alloantibodies) directed against red blood cells (RBCs) in a patient's blood. The test has three main components: agglutination, elution, and precipitation. It is commonly used in diagnosing hemolytic anemia, particularly immune-mediated hemolysis (autoimmune hemolysis or alloimmune hemolysis).

**Why the Correct Answer is Right:**
The correct answer, D, represents the key aspect of the Direct Coombs test: detection of alloantibodies (antibodies directed against foreign antigens on the RBCs of a patient). This is crucial because alloimmune hemolysis occurs when a patient's immune system produces alloantibodies against foreign antigens on RBCs from another individual during blood transfusion or pregnancy.

**Why Each Wrong Option is Incorrect:**
A. This option refers to indirect Coombs test, which detects the presence of RBC autoantibodies in a patient's blood. This is different from direct Coombs test and does not answer the question.
B. This option talks about Coombs test for detecting RBC membrane abnormalities or hypersensitivity reactions, which are not the primary purpose of the Direct Coombs test.
C. This option discusses the role of Coombs test in detecting RBC destruction caused by autoimmune or hypersensitivity reactions, which is not the primary focus of Direct Coombs test.

**Clinical Pearl:**
Direct Coombs test helps differentiate between hemolysis caused by autoimmune or hypersensitivity reactions (Option C) and hemolysis caused by alloimmune or immune-mediated hemolysis (Option D). This distinction is crucial for appropriate management and treatment options. For example, if the test is positive for alloantibodies (Option D), the patient may require a blood transfusion, while if it is positive for autoantibodies (Option C), the patient may need immunosuppressive therapy or corticosteroids to manage autoimmune hemolysis.